According to the authors of the abovementioned studies [26,27], anti-LC1 and anti-SLA autoantibodies can be regarded as serological markers of autoimmunity and need to be tested when investigating autoimmunity, especially in chronic HCV infection. This evidence concerns the gene DNAL1 and Autoimmunity.